LONDON (AP) - GlaxoSmithKline PLC says that orders for its swine flu vaccine have increased by 51 percent in two months, with total orders now standing at 440 million doses.
The company said Tuesday that the first supplies will be shipped this week. It adds that it has received 22 orders from government since Aug. 4.
GSK gained European Union approval last week for distribution of its Pandemrix vaccine. Approval by the U.S. Food and Drug Administration is pending.
Web Search powered by YAHOO!
|
LifestylesLifestyles
GSK reports heavy demand for swine flu vaccine
LONDON (AP) - GlaxoSmithKline PLC says that orders for its swine flu vaccine have increased by 51 percent in two months, with total orders now standing at 440 million doses.
By:
|
WNCT
Published: October 06, 2009
Published: October 06, 2009
Email
Facebook
Google
Twitter
Favorites
MoreAdvertisement
View More:
European Union,
Glaxosmithkline Plc,
Health_Medical_Pharma,
London,
Swine Flu,
U.S. Food And Drug Administration
Not what you're looking for? Try our quick search:
Reader Comments
*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.Deal of the Day
Advertisement
Interactive Radar
Advertisement
Featured Blogger
Reel Reviews
Updated: 02/10/2012
Nine On Your Side's Phillip Sayblack shares his take on the latest movie and dvd releases.
More Posts by Reel Reviews
Hot Topics on WNCT.com
Advertisement
Advertisement